Based on the measurements of operating efficiency obtained from Innospec's historical financial statements, Innospec may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. At this time, Innospec's Non Current Liabilities Total is relatively stable compared to the past year. As of 02/02/2026, Other Current Assets is likely to grow to about 29.8 M, while Other Current Liabilities is likely to drop slightly above 114.7 M.
The financial analysis of Innospec is a critical element in measuring its lifeblood. Investors should carefully consider Innospec's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Understanding current and past Innospec Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Innospec's financial statements are interrelated, with each one affecting the others. For example, an increase in Innospec's assets may result in an increase in income on the income statement.
Innospec competes with Chemours, Ingevity Corp, Minerals Technologies, Ashland Global, and Aris Mining. Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. Innospec Inc. was founded in 1938 and is headquartered in Englewood, Colorado. Innospec operates under Specialty Chemicals classification in the United States and is traded on NASDAQ Exchange. It employs 1900 people.
Comparative valuation techniques use various fundamental indicators to help in determining Innospec's current stock value. Our valuation model uses many indicators to compare Innospec value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Innospec competition to find correlations between indicators driving Innospec's intrinsic value. More Info.
Innospec is rated second overall in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Innospec's Return On Equity is relatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Innospec by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Most indicators from Innospec's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Innospec current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Innospec. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.
Today, most investors in Innospec Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Innospec's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Innospec growth as a starting point in their analysis.
Along with financial statement analysis, the daily predictive indicators of Innospec help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Innospec. We use our internally-developed statistical techniques to arrive at the intrinsic value of Innospec based on widely used predictive technical indicators. In general, we focus on analyzing Innospec Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Innospec's daily price indicators and compare them against related drivers.
When running Innospec's price analysis, check to measure Innospec's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innospec is operating at the current time. Most of Innospec's value examination focuses on studying past and present price action to predict the probability of Innospec's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innospec's price. Additionally, you may evaluate how the addition of Innospec to your portfolios can decrease your overall portfolio volatility.